To include your compound in the COVID-19 Resource Center, submit it here.

Exparel: Phase III data

A U.S. Phase III trial in 136 patients undergoing augmentation mammoplasty showed that

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE